Therapeutic vaccination of chronic hepatitis B patients with ABX203 (NASVAC) to prevent relapse after stopping NUCs: contrasting timing rebound between tenofovir and entecavir
Wedemeyer, H., Hui, A.J., Sukeepaisarnjaroen, W., Tangkijvanich, P., Su, W.W., Nieto, G.E.G., Gineste, P., Nitcheu, J., Crabé, S., Stepien, S., Cornberg, M., Trépo, C.Volume:
66
Year:
2017
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(17)30463-4
File:
PDF, 80 KB
english, 2017